$LH
LABCORP HOLDINGS INC. Stock $lh

$lh Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000092014820000029 Filed on May 08, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$2.824B	$2.791B
YoY Change	1.17%	-2.0%
Cost Of Revenue	$2.096B	$2.002B
YoY Change	4.71%	-3.28%
Gross Profit	$728.0M	$789.7M
YoY Change	-7.81%	1.37%
Gross Profit Margin	25.78%	28.29%
Selling, General & Admin	$395.5M	$393.8M
YoY Change	0.43%	-0.81%
% of Gross Profit	54.33%	49.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$144.6M	$135.5M
YoY Change	6.72%	-5.11%
% of Gross Profit	19.86%	17.16%
Operating Expenses	$395.5M	$393.8M
YoY Change	0.43%	-0.81%
Operating Profit	-$192.6M	$318.2M
YoY Change	-160.53%	4.19%
Interest Expense	$55.00M	$56.70M
YoY Change	-3.0%	-10.71%
% of Operating Profit		17.82%
Other Income/Expense, Net	-$75.10M	-$63.50M
YoY Change	18.27%	-0.63%
Pretax Income	-$267.7M	$254.7M
YoY Change	-205.1%	5.47%
Income Tax	$49.20M	$68.80M
% Of Pretax Income		27.01%
Net Earnings	-$317.2M	$185.6M
YoY Change	-270.91%	7.16%
Net Earnings / Revenue	-11.23%	6.65%
Basic Earnings Per Share	-$3.27	$1.88
Diluted Earnings Per Share	-$3.27	$1.86
COMMON SHARES
Basic Shares Outstanding	97.20M shares	98.60M shares
Diluted Shares Outstanding	97.20M shares	99.50M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$324.0M	$349.0M
YoY Change	-7.16%	-3.59%
Cash & Equivalents	$323.6M	$348.8M
Short-Term Investments
Other Short-Term Assets	$353.0M	$317.0M
YoY Change	11.36%	-8.65%
Inventory	$254.0M	$233.7M
Prepaid Expenses	$353.2M	$317.1M
Receivables	$1.482B	$1.563B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.891B	$2.885B
YoY Change	0.2%	-0.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.610B	$2.458B
YoY Change	6.17%	40.46%
Goodwill	$7.389B	$7.386B
YoY Change	0.04%	-3.01%
Intangibles	$3.905B	$3.885B
YoY Change	0.52%	-9.6%
Long-Term Investments	$67.00M	$67.00M
YoY Change	0.0%	15.52%
Other Assets	$430.6M	$288.2M
YoY Change	49.41%	35.88%
Total Long-Term Assets	$14.41B	$14.09B
YoY Change	2.28%	1.08%
TOTAL ASSETS
Total Short-Term Assets	$2.891B	$2.885B
Total Long-Term Assets	$14.41B	$14.09B
Total Assets	$17.30B	$16.97B
YoY Change	1.93%	0.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$568.7M	$592.2M
YoY Change	-3.97%	14.08%
Accrued Expenses	$828.1M	$797.3M
YoY Change	3.86%	6.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$1.000M
YoY Change	-100.0%	-88.89%
Long-Term Debt Due	$426.0M	$508.0M
YoY Change	-16.14%	24.21%
Total Short-Term Liabilities	$2.458B	$2.527B
YoY Change	-2.73%	20.1%
LONG-TERM LIABILITIES
Long-Term Debt	$5.790B	$5.496B
YoY Change	5.36%	-13.58%
Other Long-Term Liabilities	$369.4M	$307.3M
YoY Change	20.21%	-17.57%
Total Long-Term Liabilities	$6.160B	$5.803B
YoY Change	6.15%	-13.8%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.458B	$2.527B
Total Long-Term Liabilities	$6.160B	$5.803B
Total Liabilities	$10.26B	$9.840B
YoY Change	4.27%	0.13%
SHAREHOLDERS EQUITY
Retained Earnings	$7.529B	$7.265B
YoY Change	3.63%	14.07%
Common Stock	$9.000M	$1.413B
YoY Change	-99.36%	-28.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$1.128B
YoY Change		3.91%
Treasury Stock Shares
Shareholders Equity	$7.020B	$7.111B
YoY Change
Total Liabilities & Shareholders Equity	$17.30B	$16.97B
YoY Change	1.93%	0.83%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$317.2M	$185.6M
YoY Change	-270.91%	7.16%
Depreciation, Depletion And Amortization	$144.6M	$135.5M
YoY Change	6.72%	-5.11%
Cash From Operating Activities	$203.8M	$165.8M
YoY Change	22.92%	-7.74%
INVESTING ACTIVITIES
Capital Expenditures	$106.6M	$94.20M
YoY Change	13.16%	29.93%
Acquisitions	$0.00	$47.30M
YoY Change	-100.0%
Other Investing Activities	$0.00	-$46.30M
YoY Change	-100.0%	2472.22%
Cash From Investing Activities	-$106.6M	-$140.5M
YoY Change	-24.13%	89.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$100.0M	$100.1M
YoY Change	-0.1%	33.47%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$102.8M	-$103.2M
YoY Change	-0.39%	58.77%
NET CHANGE
Cash From Operating Activities	$203.8M	$165.8M
Cash From Investing Activities	-$106.6M	-$140.5M
Cash From Financing Activities	-$102.8M	-$103.2M
Net Change In Cash	-$13.90M	-$78.00M
YoY Change	-82.18%	-293.07%
FREE CASH FLOW
Cash From Operating Activities	$203.8M	$165.8M
Capital Expenditures	$106.6M	$94.20M
Free Cash Flow	$97.20M	$71.60M
YoY Change	35.75%	-33.21%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	97100000	shares
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000920148
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	97200000	shares
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	323600000	USD
CY2020Q1	dei	Entity File Number EntityFileNumber	1-11353
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	LABORATORY CORPORATION OF AMERICA HOLDINGS
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	337500000	USD
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3757370
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	358 South Main Street
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Burlington,
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1482200000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1543900000	USD
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27215
CY2020Q1	dei	City Area Code CityAreaCode	336
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	229-1127
CY2020Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.10 par value
CY2020Q1	dei	Trading Symbol TradingSymbol	LH
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2458000000.0	USD
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	97200000	shares
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2655800000	USD
CY2020Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	478100000	USD
CY2019Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	481400000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	254000000.0	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	244700000	USD
CY2020Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	353200000	USD
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	373700000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	2891100000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	2981200000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2609600000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2636600000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	7388500000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	7865000000.0	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3905100000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4034500000	USD
CY2020Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	67000000.0	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	84900000	USD
CY2020Q1	us-gaap	Deferred Income Taxes And Other Assets Current DeferredIncomeTaxesAndOtherAssetsCurrent	6500000	USD
CY2019Q4	us-gaap	Deferred Income Taxes And Other Assets Current DeferredIncomeTaxesAndOtherAssetsCurrent	8800000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	430600000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	435400000	USD
CY2020Q1	us-gaap	Assets Assets	17298400000	USD
CY2019Q4	us-gaap	Assets Assets	18046400000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	568700000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	632300000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	828100000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	942400000	USD
CY2020Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	432900000	USD
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	451000000.0	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	202700000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	206500000	USD
CY2020Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8200000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	8400000	USD
CY2020Q1	us-gaap	Debt Current DebtCurrent	417400000	USD
CY2019Q4	us-gaap	Debt Current DebtCurrent	415200000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	91100000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5790200000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	596600000	USD
CY2020Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	89300000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5789800000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	609800000	USD
CY2020Q1	lh	Deferred Income Taxes And Other Tax Liabilities DeferredIncomeTaxesAndOtherTaxLiabilities	943100000	USD
CY2019Q4	lh	Deferred Income Taxes And Other Tax Liabilities DeferredIncomeTaxesAndOtherTaxLiabilities	942800000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	369400000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	383200000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	10259800000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	10459300000	USD
CY2020Q1	lh	Noncontrolling Interest Mezzanine Equity NoncontrollingInterestMezzanineEquity	18500000	USD
CY2019Q4	lh	Noncontrolling Interest Mezzanine Equity NoncontrollingInterestMezzanineEquity	20100000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	9000000.0	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	9000000.0	USD
CY2020Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26800000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7529000000.0	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7903600000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-517900000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-372400000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	7020100000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	7567000000.0	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17298400000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18046400000	USD
CY2020Q1	us-gaap	Revenues Revenues	2823800000	USD
CY2019Q1	us-gaap	Revenues Revenues	2791200000	USD
CY2020Q1	us-gaap	Cost Of Revenue CostOfRevenue	2095800000	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	2001500000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	728000000.0	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	789700000	USD
CY2020Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	395500000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	393800000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62300000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57100000	USD
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	437400000	USD
CY2019Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q1	lh	Net Restructuring And Other Special Charges NetRestructuringAndOtherSpecialCharges	25400000	USD
CY2019Q1	lh	Net Restructuring And Other Special Charges NetRestructuringAndOtherSpecialCharges	20600000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-192600000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	318200000	USD
CY2020Q1	lh	Income Lossfrom Continuing Operations Before Income Taxesand Noncontrolling Interest IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest	-267700000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	55000000.0	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	56700000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-6600000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000000.0	USD
CY2020Q1	us-gaap	Investment Income Net InvestmentIncomeNet	2600000	USD
CY2019Q1	us-gaap	Investment Income Net InvestmentIncomeNet	600000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16100000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-317200000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.88
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10400000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49200000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	68800000	USD
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.27
CY2019Q1	lh	Income Lossfrom Continuing Operations Before Income Taxesand Noncontrolling Interest IncomeLossfromContinuingOperationsBeforeIncomeTaxesandNoncontrollingInterest	254700000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	185900000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-316900000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	185600000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.27
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.86
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-316900000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	185900000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-147500000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	21600000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-2700000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax	-2700000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-144800000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	24300000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	700000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	700000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-145500000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	23600000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-462400000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	209500000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-462700000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	209200000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	6971400000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	185600000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	23600000	USD
CY2019Q1	lh	Issuanceofcommonstockunderemployeeplans Issuanceofcommonstockunderemployeeplans	24700000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	19400000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25500000	USD
CY2019Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	100100000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	7111300000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	7567000000.0	USD
CY2019Q4	us-gaap	New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1 NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1	-7000000.0	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-317200000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-145500000	USD
CY2020Q1	lh	Issuanceofcommonstockunderemployeeplans Issuanceofcommonstockunderemployeeplans	26900000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	22000000.0	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17900000	USD
CY2019Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5100000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	25500000	USD
CY2020Q1	lh	Depreciation And Amortization Of Leased Assets DepreciationAndAmortizationOfLeasedAssets	57200000	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	17100000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	100000000.0	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	7020100000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-316900000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	185900000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	144600000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	135500000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	17900000	USD
CY2019Q1	lh	Depreciation And Amortization Of Leased Assets DepreciationAndAmortizationOfLeasedAssets	61200000	USD
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	437400000	USD
CY2020Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	43300000	USD
CY2019Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	7000000.0	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-46700000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	90800000	USD
CY2020Q1	lh	Increase Decreasein Unbilled Contract Receivable IncreaseDecreaseinUnbilledContractReceivable	1100000	USD
CY2019Q1	lh	Increase Decreasein Unbilled Contract Receivable IncreaseDecreaseinUnbilledContractReceivable	26400000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10600000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3400000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3000000.0	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7200000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-56500000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-28800000	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-11200000	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	5600000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-149100000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-136600000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	203800000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	165800000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	106600000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	94200000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7000000.0	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3900000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	900000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	400000	USD
CY2020Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	7900000	USD
CY2019Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3300000	USD
CY2020Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	47300000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-106600000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-140500000	USD
CY2020Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	151700000	USD
CY2019Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	133200000	USD
CY2020Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	151700000	USD
CY2019Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	133200000	USD
CY2020Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	22000000.0	USD
CY2019Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	19400000	USD
CY2020Q1	lh	Net Proceeds From Issuance Of Stock To Employees NetProceedsFromIssuanceOfStockToEmployees	26900000	USD
CY2019Q1	lh	Net Proceeds From Issuance Of Stock To Employees NetProceedsFromIssuanceOfStockToEmployees	24700000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100000000.0	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13900000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	100100000	USD
CY2020Q1	lh	Other Financing Cash Flows OtherFinancingCashFlows	7700000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-78000000.0	USD
CY2019Q1	lh	Other Financing Cash Flows OtherFinancingCashFlows	8400000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-102800000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-103200000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-8300000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-100000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	337500000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	426800000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	323600000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	348800000	USD
CY2020Q1	lh	Cost Method Investments Maximum Ownership Percentage CostMethodInvestmentsMaximumOwnershipPercentage	0.200
CY2020Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	437400000	USD
CY2020Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	20200000	USD
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;text-indent:18px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The extent to which the COVID-19 pandemic impacts the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of the COVID-19 pandemic, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of March 31, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company’s implicit price concessions and credit losses, equity investments, software, notes receivable and the carrying value of goodwill and other long-lived assets. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company’s consolidated financial statements in future reporting periods.</span></div>
CY2020Q1	lh	Percentof Revenue Contributed PercentofRevenueContributed	1
CY2019Q1	lh	Percentof Revenue Contributed PercentofRevenueContributed	1
CY2020Q1	lh	Sales Commission Amortization Period Minimum SalesCommissionAmortizationPeriodMinimum	P12M
CY2020Q1	lh	Sales Commission Amortization Period Maximum SalesCommissionAmortizationPeriodMaximum	P57M
CY2020Q1	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	30300000	USD
CY2019Q4	us-gaap	Accrued Sales Commission Current And Noncurrent AccruedSalesCommissionCurrentAndNoncurrent	28600000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	13800000	USD
CY2019Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	14900000	USD
CY2020Q1	us-gaap	Amount Of Deferred Costs Related To Long Term Contracts AmountOfDeferredCostsRelatedToLongTermContracts	44100000	USD
CY2019Q4	us-gaap	Amount Of Deferred Costs Related To Long Term Contracts AmountOfDeferredCostsRelatedToLongTermContracts	43500000	USD
CY2020Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	5300000	USD
CY2019Q1	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	4500000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3000000.0	USD
CY2019Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1800000	USD
CY2020Q1	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	480600000	USD
CY2019Q4	us-gaap	Contract With Customer Asset Gross ContractWithCustomerAssetGross	483700000	USD
CY2020Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	430900000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	449200000	USD
CY2020Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	121800000	USD
CY2019Q1	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	103600000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	19000000.0	USD
CY2019Q4	lh	Unbilled Services Allowancefor Credit Loss UnbilledServicesAllowanceforCreditLoss	2300000	USD
CY2019Q4	lh	Note Receivable Allowancefor Credit Loss NoteReceivableAllowanceforCreditLoss	0	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8500000	USD
CY2019Q4	lh	Allowancefor Credit Loss AllowanceforCreditLoss	21300000	USD
CY2020Q1	lh	Current Expected Credit Losses Opening Balance Sheet Impacton Retained Earnings CurrentExpectedCreditLossesOpeningBalanceSheetImpactonRetainedEarnings	7000000.0	USD
CY2020Q1	lh	Unbilled Services Credit Loss Expense Reversal UnbilledServicesCreditLossExpenseReversal	0	USD
CY2020Q1	lh	Note Receivable Credit Loss Expense Reversal NoteReceivableCreditLossExpenseReversal	5000000.0	USD
CY2020Q1	lh	Credit Loss Expense Reversal CreditLossExpenseReversal	13500000	USD
CY2020Q1	lh	Allowancefor Credit Loss Write Off AllowanceforCreditLossWriteOff	500000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	28900000	USD
CY2020Q1	lh	Unbilled Services Allowancefor Credit Loss UnbilledServicesAllowanceforCreditLoss	2400000	USD
CY2020Q1	lh	Note Receivable Allowancefor Credit Loss NoteReceivableAllowanceforCreditLoss	10000000.0	USD
CY2020Q1	lh	Allowancefor Credit Loss AllowanceforCreditLoss	41300000	USD
CY2020Q1	lh	Increase Decreasein Operating Income Loss IncreaseDecreaseinOperatingIncomeLoss	-17000000.0	USD
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4494900000	USD
CY2020Q1	lh	Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear Percentofremainingperformanceobligationsrecognizedasrevenueinnextyear	0.35
CY2020Q1	lh	Long Term Contracts Duration Minimum LongTermContractsDurationMinimum	P1Y
CY2020Q1	lh	Long Term Contracts Duration Maximum LongTermContractsDurationMaximum	P8Y
CY2020Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	9700000	USD
CY2019Q1	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	39700000	USD
CY2019Q3	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	110000000.0	USD
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-12200000	USD
CY2019Q3	us-gaap	Notes Receivable Fair Value Disclosure NotesReceivableFairValueDisclosure	110000000.0	USD
CY2019Q2	lh	Totalacquisitionconsiderationcashstocknotesetc. Totalacquisitionconsiderationcashstocknotesetc.	711000000.0	USD
CY2020Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	0	USD
CY2019Q2	lh	Totalacquisitionconsiderationcashstocknotesetc. Totalacquisitionconsiderationcashstocknotesetc.	711000000.0	USD
CY2020Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2832600000	USD
CY2020Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	188000000.0	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-317200000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	97200000	shares
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.27
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	185600000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	98600000	shares
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.88
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	900000	shares
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-317200000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	97200000	shares
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.27
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	185600000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	99500000	shares
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.86
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1300000	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2020Q1	lh	Net Restructuring Charges NetRestructuringCharges	25400000	USD
CY2020Q1	us-gaap	Severance Costs1 SeveranceCosts1	5100000	USD
CY2020Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	4700000	USD
CY2020Q1	us-gaap	Business Exit Costs1 BusinessExitCosts1	15800000	USD
CY2020Q1	lh	Unusedfacilityrestructuringreserves Unusedfacilityrestructuringreserves	200000	USD
CY2019Q1	lh	Net Restructuring Charges NetRestructuringCharges	20600000	USD
CY2019Q1	us-gaap	Severance Costs1 SeveranceCosts1	16800000	USD
CY2019Q1	us-gaap	Business Exit Costs1 BusinessExitCosts1	3300000	USD
CY2019Q1	lh	Employee Severance Benefits Related Restructuring Reserve Accrual Adjustment EmployeeSeveranceBenefitsRelatedRestructuringReserveAccrualAdjustment	500000	USD
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	13400000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	8800000	USD
CY2020Q1	us-gaap	Restructuring Reserve Accrual Adjustment1 RestructuringReserveAccrualAdjustment1	-300000	USD
CY2020Q1	lh	Restructuring Impairment RestructuringImpairment	4700000	USD
CY2020Q1	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	11600000	USD
CY2020Q1	lh	Restructuring Reserve Settled With Cash And Other Adjustment RestructuringReserveSettledWithCashAndOtherAdjustment	25600000	USD
CY2020Q1	us-gaap	Restructuring Reserve RestructuringReserve	13200000	USD
CY2020Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	7800000	USD
CY2020Q1	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	5400000	USD
CY2020Q1	us-gaap	Restructuring Reserve RestructuringReserve	13200000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	7865000000.0	USD
CY2020Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	422400000	USD
CY2020Q1	us-gaap	Goodwill Translation And Purchase Accounting Adjustments GoodwillTranslationAndPurchaseAccountingAdjustments	-54100000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	7388500000	USD
CY2020Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5811700000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1906600000	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3905100000	USD
CY2019Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5885600000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1851100000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4034500000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62300000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57100000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	176600000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	231800000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	225900000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	222800000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	218200000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2299900000	USD
CY2020Q1	lh	A4.625 Seniornotesdue2020 A4.625Seniornotesdue2020	415500000	USD
CY2019Q4	lh	A4.625 Seniornotesdue2020 A4.625Seniornotesdue2020	413700000	USD
CY2020Q1	lh	Shorttermdebtissuancecosts Shorttermdebtissuancecosts	300000	USD
CY2019Q4	lh	Shorttermdebtissuancecosts Shorttermdebtissuancecosts	700000	USD
CY2020Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2200000	USD
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2200000	USD
CY2020Q1	us-gaap	Debt Current DebtCurrent	417400000	USD
CY2019Q4	us-gaap	Debt Current DebtCurrent	415200000	USD
CY2020Q1	lh	A2.30seniornotesdue2024 A2.30seniornotesdue2024	400000000.0	USD
CY2019Q4	lh	A2.30seniornotesdue2024 A2.30seniornotesdue2024	400000000.0	USD
CY2020Q1	lh	A2.95seniornotesdue2029 A2.95seniornotesdue2029	650000000.0	USD
CY2019Q4	lh	A2.95seniornotesdue2029 A2.95seniornotesdue2029	650000000.0	USD
CY2019Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	375000000.0	USD
CY2020Q1	lh	Longtermdebtissuancecosts Longtermdebtissuancecosts	41300000	USD
CY2019Q4	lh	Longtermdebtissuancecosts Longtermdebtissuancecosts	42200000	USD
CY2020Q1	us-gaap	Notes Payable NotesPayable	6500000	USD
CY2019Q4	us-gaap	Notes Payable NotesPayable	7000000.0	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5790200000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5789800000	USD
CY2019Q2	lh	A2019 Term Loan A2019TermLoan	850000000.0	USD
CY2019Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	375000000.0	USD
CY2014Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1000000000.0	USD
CY2014Q4	lh	Credit Facility Optionto Increase CreditFacilityOptiontoIncrease	350000000.0	USD
CY2014Q4	lh	Credit Facility Maximum Swing Line Borrowings CreditFacilityMaximumSwingLineBorrowings	100000000.0	USD
CY2020Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	923700000	USD
CY2019Q4	lh	Senior Notes Became Due During Quarter SeniorNotesBecameDueDuringQuarter	412200000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	323600000	USD
CY2020Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	923700000	USD
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	265000000.0	shares
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000.0	shares
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q1	lh	Common Stock Repurchase Authorization Outstanding CommonStockRepurchaseAuthorizationOutstanding	900000000.0	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	600000	shares
CY2020Q1	lh	Commonstockrepurchaseaveragepurchasepricepershare Commonstockrepurchaseaveragepurchasepricepershare	178.85
CY2020Q1	us-gaap	Treasury Stock Carrying Basis TreasuryStockCarryingBasis	100000000.0	USD
CY2020Q1	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	800000000.0	shares
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-285400000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-87000000.0	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-372400000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax	-147500000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax	2700000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Reclassifications Before Tax OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax	-144800000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	700000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	700000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-432900000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-85000000.0	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-517900000	USD
CY2020Q1	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.50
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	32300000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	31700000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	32300000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	31700000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	6000000.0	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	5500000	USD
CY2020Q1	lh	Numberof Additional Parties Not Providing Consent NumberofAdditionalPartiesNotProvidingConsent	40
CY2020Q1	lh	Damages Per Violation DamagesPerViolation	500.0000	USD
CY2020Q1	lh	Non Elective Contribution NonElectiveContribution	0.03
CY2020Q1	lh	Discretionary Contribution Percentage Minimum DiscretionaryContributionPercentageMinimum	0.01
CY2020Q1	lh	Discretionary Contribution Percentage Maximum DiscretionaryContributionPercentageMaximum	0.03
CY2020Q1	lh	Defined Contribution Plan Total Expense DefinedContributionPlanTotalExpense	13500000	USD
CY2019Q1	lh	Defined Contribution Plan Total Expense DefinedContributionPlanTotalExpense	16000000.0	USD
CY2020Q1	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.045
CY2020Q1	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-93100000	USD
CY2019Q4	us-gaap	Defined Benefit Plan Funded Status Of Plan DefinedBenefitPlanFundedStatusOfPlan	-93400000	USD
CY2020Q1	lh	Fair Value Liabilities Measured On Recurring Basis Noncontrolling Interest Puts FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts	14600000	USD
CY2020Q1	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	23100000	USD
CY2020Q1	us-gaap	Fair Value Hedges At Fair Value Net FairValueHedgesAtFairValueNet	3300000	USD
CY2020Q1	us-gaap	Fair Value Hedges At Fair Value Net FairValueHedgesAtFairValueNet	3300000	USD
CY2020Q1	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	68000000.0	USD
CY2020Q1	lh	Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability	66700000	USD
CY2020Q1	lh	Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability	66700000	USD
CY2020Q1	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	6400000	USD
CY2019Q4	lh	Fair Value Liabilities Measured On Recurring Basis Noncontrolling Interest Puts FairValueLiabilitiesMeasuredOnRecurringBasisNoncontrollingInterestPuts	15800000	USD
CY2019Q4	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure	3200000	USD
CY2019Q4	us-gaap	Fair Value Hedges At Fair Value Net FairValueHedgesAtFairValueNet	1500000	USD
CY2019Q4	us-gaap	Cash Surrender Value Fair Value Disclosure CashSurrenderValueFairValueDisclosure	80200000	USD
CY2019Q4	lh	Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability	76700000	USD
CY2019Q4	lh	Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Liability FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationLiability	76700000	USD
CY2019Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	9100000	USD
CY2019Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	9900000	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-1400000	USD
CY2020Q1	lh	Contingentconsiderationadjustment Contingentconsiderationadjustment	2100000	USD
CY2020Q1	lh	Numberof Measurement Funds Available For Participant Election NumberofMeasurementFundsAvailableForParticipantElection	16
CY2020Q1	lh	Senior Notes Fair Value SeniorNotesFairValue	6007200000	USD
CY2019Q4	lh	Senior Notes Fair Value SeniorNotesFairValue	6140600000	USD
CY2020Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.02298
CY2020Q1	us-gaap	Fair Value Hedge Liabilities At Fair Value FairValueHedgeLiabilitiesAtFairValue	3300000	USD
CY2019Q4	us-gaap	Fair Value Hedge Liabilities At Fair Value FairValueHedgeLiabilitiesAtFairValue	1500000	USD
CY2020Q1	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	19900000	USD
CY2020Q1	lh	Interest Paid In Cash InterestPaidInCash	80000000.0	USD
CY2019Q1	lh	Interest Paid In Cash InterestPaidInCash	99700000	USD
CY2020Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5800000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2200000	USD
CY2020Q1	lh	Conversion Of Zero Coupon Convertible Debt ConversionOfZeroCouponConvertibleDebt	0	USD
CY2019Q1	lh	Conversion Of Zero Coupon Convertible Debt ConversionOfZeroCouponConvertibleDebt	7300000	USD
CY2020Q1	lh	Decreasein Capital Expenditures Incurredbutnotyet Paid DecreaseinCapitalExpendituresIncurredbutnotyetPaid	14000000.0	USD
CY2019Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	12100000	USD
CY2020Q1	lh	Intercompanyrevenueelimination Intercompanyrevenueelimination	22000000.0	USD
CY2019Q1	lh	Intercompanyrevenueelimination Intercompanyrevenueelimination	5500000	USD
CY2020Q1	us-gaap	Revenues Revenues	2823800000	USD
CY2019Q1	us-gaap	Revenues Revenues	2791200000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-192600000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	318200000	USD
CY2020Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-75100000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-63500000	USD
CY2020Q1	lh	Income Loss From Continuing Operations Before Income Taxes And Minority Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest	-267700000	USD
CY2019Q1	lh	Income Loss From Continuing Operations Before Income Taxes And Minority Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesAndMinorityInterest	254700000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	49200000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	68800000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-316900000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	185900000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	300000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-317200000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	185600000	USD

Files In Submission

Name	View Source	Status
0000920148-20-000029-index-headers.html	Edgar Link	pending
0000920148-20-000029-index.html	Edgar Link	pending
0000920148-20-000029.txt	Edgar Link	pending
0000920148-20-000029-xbrl.zip	Edgar Link	pending
ex311q12020.htm	Edgar Link	pending
ex312q12020.htm	Edgar Link	pending
ex32q12020.htm	Edgar Link	pending
exhibit101amendment.htm	Edgar Link	pending
exhibit101amendment001.jpg	Edgar Link	pending
exhibit101amendment002.jpg	Edgar Link	pending
exhibit101amendment003.jpg	Edgar Link	pending
exhibit101amendment004.jpg	Edgar Link	pending
exhibit101amendment005.jpg	Edgar Link	pending
exhibit101amendment006.jpg	Edgar Link	pending
exhibit101amendment007.jpg	Edgar Link	pending
exhibit101amendment008.jpg	Edgar Link	pending
exhibit101amendment009.jpg	Edgar Link	pending
exhibit101amendment010.jpg	Edgar Link	pending
exhibit101amendment011.jpg	Edgar Link	pending
exhibit101amendment012.jpg	Edgar Link	pending
exhibit101amendment013.jpg	Edgar Link	pending
exhibit101amendment014.jpg	Edgar Link	pending
exhibit101amendment015.jpg	Edgar Link	pending
exhibit101amendment016.jpg	Edgar Link	pending
exhibit101amendment017.jpg	Edgar Link	pending
exhibit101amendment018.jpg	Edgar Link	pending
exhibit101amendment019.jpg	Edgar Link	pending
exhibit101amendment020.jpg	Edgar Link	pending
exhibit101amendment021.jpg	Edgar Link	pending
exhibit101amendment022.jpg	Edgar Link	pending
exhibit101amendment023.jpg	Edgar Link	pending
exhibit101amendment024.jpg	Edgar Link	pending
exhibit101amendment025.jpg	Edgar Link	pending
exhibit101amendment026.jpg	Edgar Link	pending
exhibit101amendment027.jpg	Edgar Link	pending
exhibit101amendment028.jpg	Edgar Link	pending
exhibit101amendment029.jpg	Edgar Link	pending
exhibit101amendment030.jpg	Edgar Link	pending
exhibit101amendment031.jpg	Edgar Link	pending
exhibit101amendment032.jpg	Edgar Link	pending
exhibit101amendment033.jpg	Edgar Link	pending
exhibit101amendment034.jpg	Edgar Link	pending
exhibit101amendment035.jpg	Edgar Link	pending
exhibit101amendment036.jpg	Edgar Link	pending
exhibit101amendment037.jpg	Edgar Link	pending
exhibit101amendment038.jpg	Edgar Link	pending
exhibit101amendment039.jpg	Edgar Link	pending
exhibit101amendment040.jpg	Edgar Link	pending
exhibit101amendment041.jpg	Edgar Link	pending
exhibit101amendment042.jpg	Edgar Link	pending
exhibit101amendment043.jpg	Edgar Link	pending
exhibit101amendment044.jpg	Edgar Link	pending
exhibit101amendment045.jpg	Edgar Link	pending
exhibit101amendment046.jpg	Edgar Link	pending
exhibit101amendment047.jpg	Edgar Link	pending
exhibit101amendment048.jpg	Edgar Link	pending
exhibit101amendment049.jpg	Edgar Link	pending
exhibit101amendment050.jpg	Edgar Link	pending
exhibit101amendment051.jpg	Edgar Link	pending
exhibit101amendment052.jpg	Edgar Link	pending
exhibit101amendment053.jpg	Edgar Link	pending
exhibit101amendment054.jpg	Edgar Link	pending
exhibit101amendment055.jpg	Edgar Link	pending
exhibit101amendment056.jpg	Edgar Link	pending
exhibit101amendment057.jpg	Edgar Link	pending
exhibit101amendment058.jpg	Edgar Link	pending
exhibit101amendment059.jpg	Edgar Link	pending
exhibit101amendment060.jpg	Edgar Link	pending
exhibit101amendment061.jpg	Edgar Link	pending
exhibit101amendment062.jpg	Edgar Link	pending
exhibit101amendment063.jpg	Edgar Link	pending
exhibit101amendment064.jpg	Edgar Link	pending
exhibit101amendment065.jpg	Edgar Link	pending
exhibit101amendment066.jpg	Edgar Link	pending
exhibit101amendment067.jpg	Edgar Link	pending
exhibit101amendment068.jpg	Edgar Link	pending
exhibit101amendment069.jpg	Edgar Link	pending
exhibit101amendment070.jpg	Edgar Link	pending
exhibit101amendment071.jpg	Edgar Link	pending
exhibit101amendment072.jpg	Edgar Link	pending
exhibit101amendment073.jpg	Edgar Link	pending
exhibit101amendment074.jpg	Edgar Link	pending
exhibit101amendment075.jpg	Edgar Link	pending
exhibit101amendment076.jpg	Edgar Link	pending
exhibit101amendment077.jpg	Edgar Link	pending
exhibit101amendment078.jpg	Edgar Link	pending
exhibit101amendment079.jpg	Edgar Link	pending
exhibit101amendment080.jpg	Edgar Link	pending
exhibit101amendment081.jpg	Edgar Link	pending
exhibit101amendment082.jpg	Edgar Link	pending
exhibit101amendment083.jpg	Edgar Link	pending
exhibit101amendment084.jpg	Edgar Link	pending
exhibit101amendment085.jpg	Edgar Link	pending
exhibit101amendment086.jpg	Edgar Link	pending
exhibit101amendment087.jpg	Edgar Link	pending
exhibit101amendment088.jpg	Edgar Link	pending
exhibit101amendment089.jpg	Edgar Link	pending
exhibit101amendment090.jpg	Edgar Link	pending
exhibit101amendment091.jpg	Edgar Link	pending
exhibit101amendment092.jpg	Edgar Link	pending
exhibit101amendment093.jpg	Edgar Link	pending
exhibit101amendment094.jpg	Edgar Link	pending
exhibit101amendment095.jpg	Edgar Link	pending
exhibit101amendment096.jpg	Edgar Link	pending
exhibit101amendment097.jpg	Edgar Link	pending
exhibit101amendment098.jpg	Edgar Link	pending
exhibit101amendment099.jpg	Edgar Link	pending
exhibit102amendment.htm	Edgar Link	pending
exhibit102amendment001.jpg	Edgar Link	pending
exhibit102amendment002.jpg	Edgar Link	pending
exhibit102amendment003.jpg	Edgar Link	pending
exhibit102amendment004.jpg	Edgar Link	pending
exhibit102amendment005.jpg	Edgar Link	pending
exhibit102amendment006.jpg	Edgar Link	pending
exhibit102amendment007.jpg	Edgar Link	pending
exhibit102amendment008.jpg	Edgar Link	pending
exhibit102amendment009.jpg	Edgar Link	pending
exhibit102amendment010.jpg	Edgar Link	pending
exhibit102amendment011.jpg	Edgar Link	pending
exhibit102amendment012.jpg	Edgar Link	pending
exhibit102amendment013.jpg	Edgar Link	pending
exhibit102amendment014.jpg	Edgar Link	pending
exhibit102amendment015.jpg	Edgar Link	pending
exhibit102amendment016.jpg	Edgar Link	pending
exhibit102amendment017.jpg	Edgar Link	pending
exhibit102amendment018.jpg	Edgar Link	pending
exhibit102amendment019.jpg	Edgar Link	pending
exhibit102amendment020.jpg	Edgar Link	pending
exhibit102amendment021.jpg	Edgar Link	pending
exhibit102amendment022.jpg	Edgar Link	pending
exhibit102amendment023.jpg	Edgar Link	pending
exhibit102amendment024.jpg	Edgar Link	pending
exhibit102amendment025.jpg	Edgar Link	pending
exhibit102amendment026.jpg	Edgar Link	pending
exhibit102amendment027.jpg	Edgar Link	pending
exhibit102amendment028.jpg	Edgar Link	pending
exhibit102amendment029.jpg	Edgar Link	pending
exhibit102amendment030.jpg	Edgar Link	pending
exhibit102amendment031.jpg	Edgar Link	pending
exhibit102amendment032.jpg	Edgar Link	pending
exhibit102amendment033.jpg	Edgar Link	pending
exhibit102amendment034.jpg	Edgar Link	pending
exhibit102amendment035.jpg	Edgar Link	pending
exhibit102amendment036.jpg	Edgar Link	pending
exhibit102amendment037.jpg	Edgar Link	pending
exhibit102amendment038.jpg	Edgar Link	pending
exhibit102amendment039.jpg	Edgar Link	pending
exhibit102amendment040.jpg	Edgar Link	pending
exhibit102amendment041.jpg	Edgar Link	pending
exhibit102amendment042.jpg	Edgar Link	pending
exhibit102amendment043.jpg	Edgar Link	pending
exhibit102amendment044.jpg	Edgar Link	pending
exhibit102amendment045.jpg	Edgar Link	pending
exhibit102amendment046.jpg	Edgar Link	pending
exhibit102amendment047.jpg	Edgar Link	pending
exhibit102amendment048.jpg	Edgar Link	pending
exhibit102amendment049.jpg	Edgar Link	pending
exhibit102amendment050.jpg	Edgar Link	pending
exhibit102amendment051.jpg	Edgar Link	pending
exhibit102amendment052.jpg	Edgar Link	pending
exhibit102amendment053.jpg	Edgar Link	pending
exhibit102amendment054.jpg	Edgar Link	pending
exhibit102amendment055.jpg	Edgar Link	pending
exhibit102amendment056.jpg	Edgar Link	pending
exhibit102amendment057.jpg	Edgar Link	pending
exhibit102amendment058.jpg	Edgar Link	pending
exhibit102amendment059.jpg	Edgar Link	pending
exhibit102amendment060.jpg	Edgar Link	pending
exhibit102amendment061.jpg	Edgar Link	pending
exhibit102amendment062.jpg	Edgar Link	pending
exhibit102amendment063.jpg	Edgar Link	pending
exhibit102amendment064.jpg	Edgar Link	pending
exhibit102amendment065.jpg	Edgar Link	pending
exhibit102amendment066.jpg	Edgar Link	pending
exhibit102amendment067.jpg	Edgar Link	pending
exhibit102amendment068.jpg	Edgar Link	pending
exhibit102amendment069.jpg	Edgar Link	pending
exhibit102amendment070.jpg	Edgar Link	pending
exhibit102amendment071.jpg	Edgar Link	pending
exhibit102amendment072.jpg	Edgar Link	pending
exhibit102amendment073.jpg	Edgar Link	pending
exhibit102amendment074.jpg	Edgar Link	pending
exhibit102amendment075.jpg	Edgar Link	pending
exhibit102amendment076.jpg	Edgar Link	pending
exhibit102amendment077.jpg	Edgar Link	pending
exhibit102amendment078.jpg	Edgar Link	pending
exhibit102amendment079.jpg	Edgar Link	pending
exhibit102amendment080.jpg	Edgar Link	pending
exhibit102amendment081.jpg	Edgar Link	pending
exhibit102amendment082.jpg	Edgar Link	pending
exhibit102amendment083.jpg	Edgar Link	pending
exhibit102amendment084.jpg	Edgar Link	pending
exhibit102amendment085.jpg	Edgar Link	pending
exhibit102amendment086.jpg	Edgar Link	pending
exhibit102amendment087.jpg	Edgar Link	pending
exhibit102amendment088.jpg	Edgar Link	pending
exhibit102amendment089.jpg	Edgar Link	pending
exhibit102amendment090.jpg	Edgar Link	pending
exhibit102amendment091.jpg	Edgar Link	pending
exhibit102amendment092.jpg	Edgar Link	pending
exhibit102amendment093.jpg	Edgar Link	pending
exhibit102amendment094.jpg	Edgar Link	pending
exhibit102amendment095.jpg	Edgar Link	pending
exhibit102amendment096.jpg	Edgar Link	pending
exhibit102amendment097.jpg	Edgar Link	pending
exhibit102amendment098.jpg	Edgar Link	pending
exhibit102amendment099.jpg	Edgar Link	pending
exhibit102amendment100.jpg	Edgar Link	pending
exhibit102amendment101.jpg	Edgar Link	pending
exhibit102amendment102.jpg	Edgar Link	pending
exhibit102amendment103.jpg	Edgar Link	pending
exhibit102amendment104.jpg	Edgar Link	pending
exhibit102amendment105.jpg	Edgar Link	pending
exhibit102amendment106.jpg	Edgar Link	pending
exhibit102amendment107.jpg	Edgar Link	pending
exhibit102amendment108.jpg	Edgar Link	pending
exhibit102amendment109.jpg	Edgar Link	pending
exhibit102amendment110.jpg	Edgar Link	pending
exhibit102amendment111.jpg	Edgar Link	pending
exhibit102amendment112.jpg	Edgar Link	pending
exhibit102amendment113.jpg	Edgar Link	pending
exhibit102amendment114.jpg	Edgar Link	pending
exhibit102amendment115.jpg	Edgar Link	pending
exhibit102amendment116.jpg	Edgar Link	pending
exhibit102amendment117.jpg	Edgar Link	pending
exhibit102amendment118.jpg	Edgar Link	pending
exhibit102amendment119.jpg	Edgar Link	pending
exhibit102amendment120.jpg	Edgar Link	pending
exhibit102amendment121.jpg	Edgar Link	pending
exhibit102amendment122.jpg	Edgar Link	pending
exhibit102amendment123.jpg	Edgar Link	pending
exhibit102amendment124.jpg	Edgar Link	pending
exhibit102amendment125.jpg	Edgar Link	pending
exhibit102amendment126.jpg	Edgar Link	pending
exhibit102amendment127.jpg	Edgar Link	pending
exhibit102amendment128.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lh-20200331.xsd	Edgar Link	pending
lh-20200331_cal.xml	Edgar Link	unprocessable
lh-20200331_def.xml	Edgar Link	unprocessable
lh-20200331_lab.xml	Edgar Link	unprocessable
lh-20200331_pre.xml	Edgar Link	unprocessable
lh202010-qq1projectfile.htm	Edgar Link	pending
lh202010-qq1projectfile_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LH
LABCORP HOLDINGS INC. Stock $lh

2020 Q1 Form 10-Q Financial Statement

#000092014820000029 Filed on May 08, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LH LABCORP HOLDINGS INC. Stock $lh

2020 Q1 Form 10-Q Financial Statement

#000092014820000029 Filed on May 08, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LH
LABCORP HOLDINGS INC. Stock $lh